Long Term Outcomes in Thoracic Transplant Recipients After Conversion to Everolimus With Reduced Calcineurin Inhibitor Within a Multicenter, Open-Label, Randomized Trial
Maura Iversen
Part of the Medicine and Health Sciences Commons
Part of the Medicine and Health Sciences Commons